This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arikan, S. Articles by Rex, J. H. Search for Related Content PubMed PubMed Citation Articles by Arikan, S. Articles by Rex, J. H.

Journal of Clinical Microbiology, December 1999, p. 3946-3951, Vol. 37, No. 12
0095-1137/99/$04.00+0

Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and Fusarium Species

Sevtap Arikan,^* Mario Lozano-Chiu, Victor Paetznick, Sunaina Nangia, and John H. Rex

Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School, Houston, Texas 77030

Received 9 April 1999/Returned for modification 20 May 1999/Accepted 21 August 1999

We compared the activities of amphotericin B, itraconazole, and voriconazole against clinical Aspergillus (n = 82) and Fusarium (n = 22) isolates by a microdilution method adopted from the National Committee for Clinical Laboratory Standards (NCCLS-M27A). RPMI 1640 (RPMI), RPMI 1640 supplemented to 2% glucose (RPMI-2), and antibiotic medium 3 supplemented to 2% glucose (AM3) were used as test media. MICs were determined after 24, 48, and 72 h. A narrow range of amphotericin B MICs was observed for Aspergillus isolates, with minor variations among species. MICs for Fusarium isolates were higher than those for Aspergillus isolates. MICs of itraconazole were prominently high for two previously defined itraconazole-resistant Aspergillus fumigatus isolates and Fusarium solani. Voriconazole showed good in vitro activity against itraconazole-resistant isolates, but the MICs of voriconazole for F. solani were high. RPMI was the most efficient medium for detection of itraconazole-resistant isolates, followed by RPMI-2. While the significance remains unclear, AM3 lowered the MICs, particularly those of amphotericin B.

---

^* Corresponding author. Present address: Department of Clinical Microbiology and Microbiology, Hacettepe University Medical School, 06100 Ankara, Turkey. Phone: 90 312 3051562. Fax: 90 312 3115250. E-mail: sarikan{at}rorqual.cc.metu.edu.tr.

Present address: Departamento de Investigación Glaxo Wellcome, S.A., 28760 Tres Cantos, Madrid, Spain.

---

Journal of Clinical Microbiology, December 1999, p. 3946-3951, Vol. 37, No. 12
0095-1137/99/$04.00+0

This article has been cited by other articles:

• Tortorano, A. M., Prigitano, A., Dho, G., Esposto, M. C., Gianni, C., Grancini, A., Ossi, C., Viviani, M. A. (2008). Species Distribution and In Vitro Antifungal Susceptibility Patterns of 75 Clinical Isolates of Fusarium spp. from Northern Italy. Antimicrob. Agents Chemother. 52: 2683-2685 [Abstract] [Full Text]  
• Nucci, M., Anaissie, E. (2007). Fusarium Infections in Immunocompromised Patients. Clin. Microbiol. Rev. 20: 695-704 [Abstract] [Full Text]  
• O'Donnell, K., Sarver, B. A. J., Brandt, M., Chang, D. C., Noble-Wang, J., Park, B. J., Sutton, D. A., Benjamin, L., Lindsley, M., Padhye, A., Geiser, D. M., Ward, T. J. (2007). Phylogenetic Diversity and Microsphere Array-Based Genotyping of Human Pathogenic Fusaria, Including Isolates from the Multistate Contact Lens-Associated U.S. Keratitis Outbreaks of 2005 and 2006. J. Clin. Microbiol. 45: 2235-2248 [Abstract] [Full Text]  
• Lalitha, P., Shapiro, B. L., Srinivasan, M., Prajna, N. V., Acharya, N. R., Fothergill, A. W., Ruiz, J., Chidambaram, J. D., Maxey, K. J., Hong, K. C., McLeod, S. D., Lietman, T. M. (2007). Antimicrobial Susceptibility of Fusarium, Aspergillus, and Other Filamentous Fungi Isolated From Keratitis. Arch Ophthalmol 125: 789-793 [Abstract] [Full Text]  
• Shen, Y.-C., Wang, M.-Y., Wang, C.-Y., Tsai, T.-C., Tsai, H.-Y., Lee, Y.-F., Wei, L.-C. (2007). Clearance of Intravitreal Voriconazole. IOVS 48: 2238-2241 [Abstract] [Full Text]  
• Fernandez-Torres, B., Carrillo-Munoz, A., Inza, I., Guarro, J. (2006). Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes.. Antimicrob. Agents Chemother. 50: 2222-2224 [Abstract] [Full Text]  
• Heyn, K., Tredup, A., Salvenmoser, S., Muller, F.-M. C. (2005). Effect of Voriconazole Combined with Micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob. Agents Chemother. 49: 5157-5159 [Abstract] [Full Text]  
• Gil-Lamaignere, C., Hess, R., Salvenmoser, S., Heyn, K., Kappe, R., Muller, F.-M. C. (2005). Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. J Antimicrob Chemother 55: 1016-1019 [Abstract] [Full Text]  
• Palanisamy, A., Chao, S. D., Fouts, M., Kerr, D. (2005). Central nervous system aspergillosis in an immunocompetent patient: Cure in a hospice setting with very high-dose itraconazole. AM J HOSP PALLIAT CARE 22: 139-144 [Abstract]  
• Hsueh, P.-R., Lau, Y.-J., Chuang, Y.-C., Wan, J.-H., Huang, W.-K., Shyr, J.-M., Yan, J.-J., Yu, K.-W., Wu, J.-J., Ko, W.-C., Yang, Y.-C., Liu, Y.-C., Teng, L.-J., Liu, C.-Y., Luh, K.-T. (2005). Antifungal Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans, and Aspergillus Species from Taiwan: Surveillance of Multicenter Antimicrobial Resistance in Taiwan Program Data from 2003. Antimicrob. Agents Chemother. 49: 512-517 [Abstract] [Full Text]  
• Graybill, J. R., Hernandez, S., Bocanegra, R., Najvar, L. K. (2004). Antifungal Therapy of Murine Aspergillus terreus Infection. Antimicrob. Agents Chemother. 48: 3715-3719 [Abstract] [Full Text]  
• Serrano, M. C., Ramirez, M., Morilla, D., Valverde, A., Chavez, M., Espinel-Ingroff, A., Claro, R., Fernandez, A., Almeida, C., Martin-Mazuelos, E. (2004). A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.. J Antimicrob Chemother 53: 739-742 [Abstract] [Full Text]  
• Guarro, J., Rubio, C., Gene, J., Cano, J., Gil, J., Benito, R., Moranderia, M. J., Miguez, E. (2003). Case of Keratitis Caused by an Uncommon Fusarium Species. J. Clin. Microbiol. 41: 5823-5826 [Abstract] [Full Text]  
• Ramani, R., Gangwar, M., Chaturvedi, V. (2003). Flow Cytometry Antifungal Susceptibility Testing of Aspergillus fumigatus and Comparison of Mode of Action of Voriconazole vis-a-vis Amphotericin B and Itraconazole. Antimicrob. Agents Chemother. 47: 3627-3629 [Abstract] [Full Text]  
• Serrano, M. C., Morilla, D., Valverde, A., Chavez, M., Espinel-Ingroff, A., Claro, R., Ramirez, M., Mazuelos, E. M. (2003). Comparison of Etest with Modified Broth Microdilution Method for Testing Susceptibility of Aspergillus spp. to Voriconazole. J. Clin. Microbiol. 41: 5270-5272 [Abstract] [Full Text]  
• Lionakis, M. S., Lewis, R. E., Samonis, G., Kontoyiannis, D. P. (2003). Pentamidine Is Active In Vitro against Fusarium Species. Antimicrob. Agents Chemother. 47: 3252-3259 [Abstract] [Full Text]  
• Durand-Joly, I., Alfandari, S., Benchikh, Z., Rodrigue, M., Espinel-Ingroff, A., Catteau, B., Cordevant, C., Camus, D., Dei-Cas, E., Bauters, F., Delhaes, L., De Botton, S. (2003). Successful Outcome of Disseminated Fusarium Infection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia. J. Clin. Microbiol. 41: 4898-4900 [Abstract] [Full Text]  
• Graybill, J. R., Najvar, L. K., Gonzalez, G. M., Hernandez, S., Bocanegra, R. (2003). Improving the mouse model for studying the efficacy of voriconazole. J Antimicrob Chemother 51: 1373-1376 [Abstract] [Full Text]  
• Pearson, M. M, Rogers, P D., Cleary, J. D, Chapman, S. W (2003). Voriconazole: A New Triazole Antifungal Agent. The Annals of Pharmacotherapy 37: 420-432 [Abstract] [Full Text]  
• Paphitou, N. I., Ostrosky-Zeichner, L., Paetznick, V. L., Rodriguez, J. R., Chen, E., Rex, J. H. (2002). In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results. Antimicrob. Agents Chemother. 46: 3298-3300 [Abstract] [Full Text]  
• Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A., Rinaldi, M. G. (2002). Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative Study. J. Clin. Microbiol. 40: 3776-3781 [Abstract] [Full Text]  
• Letscher-Bru, V., Campos, F., Waller, J., Randriamahazaka, R., Candolfi, E., Herbrecht, R. (2002). Successful Outcome of Treatment of a Disseminated Infection Due to Fusarium dimerum in a Leukemia Patient. J. Clin. Microbiol. 40: 1100-1102 [Abstract] [Full Text]  
• Hayashi, S., Naitoh, K., Matsubara, S., Nakahara, Y., Nagasawa, Z., Tanabe, I., Kusaba, K., Tadano, J., Nishimura, K., Sigler, L. (2002). Pulmonary Colonization by Chrysosporium zonatum Associated with Allergic Inflammation in an Immunocompetent Subject. J. Clin. Microbiol. 40: 1113-1115 [Abstract] [Full Text]  
• Arikan, S., Lozano-Chiu, M., Paetznick, V., Rex, J. H. (2002). In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp.. Antimicrob. Agents Chemother. 46: 245-247 [Abstract] [Full Text]  
• Espinel-Ingroff, A. (2001). In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi. J. Clin. Microbiol. 39: 954-958 [Abstract] [Full Text]  
• Arikan, S., Lozano-Chiu, M., Paetznick, V., Rex, J. H. (2001). In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates. Antimicrob. Agents Chemother. 45: 327-330 [Abstract] [Full Text]  
• Sullivan, K. M., Dykewicz, C. A., Longworth, D. L., Boeckh, M., Baden, L. R., Rubin, R. H., Sepkowitz, K. A. (2001). Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond. ASH Education Book 2001: 392-421 [Abstract] [Full Text]